(±)-1-Amino-cis-3-phosphonocyclohexanecarboxylic acid

Discontinued Product

0191 has been discontinued.

View all Non-selective Metabotropic Glutamate products.
说明: Analogue of DL-AP4 (0101)
说明书
引用文献
评论
文献 (2)

生物活性

Conformationally restricted analogue of AP4.

技术数据

分子量 223.17
储存 Store at RT
CAS Number 103439-20-9

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

产品说明书

分析证书目前不在网上提供。
请联系客户服务

参考文献

参考文献是支持产品生物活性的出版物。

Crooks et al (1986) Cyclic analogues of 2-amino-4-phosphonobutanoic acid (AP4) and their inhibition of hippocampal excitatory transmission and displacement of [3H]AP4 binding. J.Med.Chem. 29 1988 PMID: 3020251

关键词: (±)-1-Amino-cis-3-phosphonocyclohexanecarboxylic acid, (±)-1-Amino-cis-3-phosphonocyclohexanecarboxylic acid supplier, Non-selective, mGlu, 0191, Tocris Bioscience

篇 (±)-1-Amino-cis-3-phosphonocyclohexanecarboxylic acid 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 (±)-1-Amino-cis-3-phosphonocyclohexanecarboxylic acid 的引用文献。

(±)-1-Amino-cis-3-phosphonocyclohexanecarboxylic acid 的评论

目前没有该产品的评论。 Be the first to review (±)-1-Amino-cis-3-phosphonocyclohexanecarboxylic acid and earn rewards!

Have you used (±)-1-Amino-cis-3-phosphonocyclohexanecarboxylic acid?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Metabotropic Glutamate Receptors Scientific Review

Metabotropic Glutamate Receptors Scientific Review

Written by Francine Acher, this review discusses the pharmacology and therapeutic potential of mGlu receptors, and the compounds acting upon them; compounds available from Tocris are listed.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.